Arellano, Josefina G.

HRN: 05-28-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2023
CEFTRIAXONE 1G (VIAL)
02/20/2023
02/26/2023
IVT
2g
OD
Pneumonia, UTI
Waiting Final Action 
02/21/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/21/2023
02/25/2023
ORAL
500 Mg
OD
CAP HR
Waiting Final Action 
02/22/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/22/2023
03/15/2023
IV
4.5gram
Q6hrs
Septicemia
Waiting Final Action 
03/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/01/2023
03/07/2023
IV
4.5g
Q6
CAP HR (Antibiotic Extension)
Waiting Final Action 
03/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/02/2023
03/08/2023
IV
2.25g
Q6
CAP HR (Revised From 4.5g Q6)
Waiting Final Action 
03/06/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/06/2023
03/12/2023
IV
600mg
Q8
CAP HR
Waiting Final Action 
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/14/2023
IV
1g
Q12
Cap HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: